Circulating Tumor DNA as a Marker for Treatment Response in Metastatic Melanoma Patients Using Next-Generation Sequencing-A Prospective Feasibility Study.
Berger M, Thueringer A, Franz D, Dandachi N, Talakić E, Richtig G, Richtig E, Rohrer PM, Koch L, Wolf IH, Koch C, Rainer BM, Koeller M, Pichler M, Gerritsmann H, Kashofer K, Aigelsreiter A.
Berger M, et al. Among authors: talakic e.
Cancers (Basel). 2021 Jun 21;13(12):3101. doi: 10.3390/cancers13123101.
Cancers (Basel). 2021.
PMID: 34205831
Free PMC article.